Navigation Links
Elsevier introduces innovative new pharmacology text
Date:12/7/2009

Philadelphia, PA, 7 December 2009 Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the early success and rapid acceptance of its recently released Pharmacology and Therapeutics: Principles to Practice (http://www.us.elsevierhealth.com/isbn/9781416032915/Pharmacology-and-Therapeutics), an innovative new pharmacology textbook designed to better meet the needs of today's residents and practitioners. In just a few short months since its introduction, the book has garnered critical acclaim and has earned its place among other more established pharmacology reference books (http://www.us.elsevierhealth.com/medicine/pharmacology).

Up until now, pharmacology references have focused on either the basic or clinical aspects of the field. By contrast, Pharmacology and Therapeutics encompasses the entire continuum from underlying science through innovation, translation, regulation, and clinical implementation, providing the integrated perspectives that are needed to fully master human therapeutics today.

Edited by Drs. Scott Waldman and Andre Terzic both past presidents of the American Society for Clinical Pharmacology and Therapeutics the book features contributions from many of the most respected names in pharmacology. These authors, all leaders in their respective disciplines, establish the standards for translating fundamental observations in the laboratory into novel therapeutic approaches for managing patients including rapidly growing areas such as pharmacogenetics and pharmacogenomics, regenerative pharmacology, stem cell therapies, and the emerging field of individualized medicine. Evidence-based therapeutic guidelines are included throughout, where available, as are appropriate discussions of nutrition, complementary and alternative medicines, nutraceuticals, and dietary supplements.

"I applaud the Editors for bringing together, between the covers of this first edition, a superb textbook bridging basic and clinical pharmacology, from classic principles to future concepts," writes Nobel Laureate Ferid Murad, MD, PhD in the book's Foreword. "This exciting textbook will be invaluable to students, scholars, and professionals across the practice in human therapeutics."

"This is an outstanding textbook that connects the recent advances in basic principles with the practice of medicine," added Thomas L. Pazdernik, PhD, University of Kansas Medical Center. "It is a must-have book for those involved in drug discovery, translational research, and the teaching of evidence-based medicine."

In its June 2009 issue, the British Journal of Hospital Medicine cites the narrative as " so easy to read that it makes extracting the information from the pages almost effortless. Every chapter is supported by a good selection of references to original research and review articles, both old and new, and the whole text is available online allowing it to be accessed wherever there is internet connection."


'/>"/>

Contact: Tom Reller
t.reller@elsevier.com
212-462-1912
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier launches new journal: Stem Cell Research
2. Elsevier announces new journal on inflammatory bowel diseases
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
5. Elsevier journals participate widely in global theme issue on poverty and human development
6. ScienceDirect to host French-language journals from Elsevier Masson
7. Elseviers "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights
8. Elseviers WiserWiki allows physicians to update evidence-based medical information
9. Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars
10. Elsevier Foundation announces grants for innovative libraries and new scholars
11. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology: